Enterprise Value
0.00
Cash
52.2M
Avg Qtr Burn
N/A
Short % of Float
3.79%
Insider Ownership
13.13%
Institutional Own.
0.17%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NYX-783 Details Psychiatric disorder, Post-traumatic stress disorder | Failed Discontinued | |
NYX-2925 Details Central nervous system illness, Fibromyalgia | Failed Discontinued | |
NYX-458 Details Central nervous system illness, Mental health, Parkinson's disease | Failed Discontinued | |
NYX-2925 Details Diabetic peripheral neuropathy | Failed Discontinued |